These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Nasr SH; Said SM; Valeri AM; Stokes MB; Masani NN; D'Agati VD; Markowitz GS Clin J Am Soc Nephrol; 2009 Feb; 4(2):299-308. PubMed ID: 19158367 [TBL] [Abstract][Full Text] [Related]
3. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis. Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C Front Immunol; 2020; 11():607261. PubMed ID: 33613528 [TBL] [Abstract][Full Text] [Related]
4. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis. van Daalen EE; Jennette JC; McAdoo SP; Pusey CD; Alba MA; Poulton CJ; Wolterbeek R; Nguyen TQ; Goldschmeding R; Alchi B; Griffiths M; de Zoysa JR; Vincent B; Bruijn JA; Bajema IM Clin J Am Soc Nephrol; 2018 Jan; 13(1):63-72. PubMed ID: 29162595 [TBL] [Abstract][Full Text] [Related]
5. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Nasr SH; D'Agati VD; Park HR; Sterman PL; Goyzueta JD; Dressler RM; Hazlett SM; Pursell RN; Caputo C; Markowitz GS Clin J Am Soc Nephrol; 2008 May; 3(3):682-90. PubMed ID: 18287252 [TBL] [Abstract][Full Text] [Related]
6. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis. Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219 [TBL] [Abstract][Full Text] [Related]
11. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976 [TBL] [Abstract][Full Text] [Related]
12. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis. Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700 [TBL] [Abstract][Full Text] [Related]
13. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672 [TBL] [Abstract][Full Text] [Related]
14. Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis. Nasr SH; D'Agati VD; Said SM; Stokes MB; Appel GB; Valeri AM; Markowitz GS Clin J Am Soc Nephrol; 2008 Sep; 3(5):1282-8. PubMed ID: 18508945 [TBL] [Abstract][Full Text] [Related]
15. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043 [TBL] [Abstract][Full Text] [Related]
16. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis]. Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510 [TBL] [Abstract][Full Text] [Related]
17. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort. Alchi B; Griffiths M; Sivalingam M; Jayne D; Farrington K Nephrol Dial Transplant; 2015 May; 30(5):814-21. PubMed ID: 25609740 [TBL] [Abstract][Full Text] [Related]
18. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy. Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422 [TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with anti-GBM crescentic glomerulonephritis. Yang G; Tang Z; Chen Y; Zeng C; Chen H; Liu Z; Li L Clin Nephrol; 2005 Jun; 63(6):423-8. PubMed ID: 15960143 [TBL] [Abstract][Full Text] [Related]
20. Patterns of glomerulonephritis with crescents: Experience at a tertiary medical center in Saudi Arabia. Al-Hussain T; Asiri S; Amer S; Al Mana H; Akhtar M Saudi J Kidney Dis Transpl; 2017; 28(3):532-537. PubMed ID: 28540889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]